Drug
TD 3504
TD 3504: highest development phase Phase 1, developed by Theravance Biopharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Theravance Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| TD-3504 NCT03103412 | Phase 1 | Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects |
Latest
No recent events.
Follow TD 3504 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.